ClinicaliQ Trial Snapshot
- Outcomes of Drug Coated Balloon Angioplasty, A UK Real Life Experience From 2009 to 2015 — Active Not Recruiting • Cardiology / Cardiovascular • NCT03603210.
- Drug-coated balloon angioplasty was safe and effective for treating coronary artery disease in this UK hospital study from 2009-2015.
Verify eligibility, endpoints and current status on the original ClinicalTrials.gov registry before acting on this summary.
Use This Page For
- Quick orientation before opening the registry record.
- Checking recruitment status, phase and sponsor at a glance.
- Connecting this trial to nearby guidelines, Drug Science and education.
What This Trial Is Studying
This is a single center, retrospective, observational cohort study to assess the safety and efficacy of drug coated balloon (DCB) angioplasty in all forms of coronary artery disease. The Investigators intend to report outcomes of all patients who received DCB angioplasty at their center during the above mentioned period for up to 10 years. Conditions: Ischaemic Heart Disease Interventions: Drug coated balloon angioplasty Lead Sponsor: Norfolk and Norwich University Hospitals NHS Foundation Trust Planned Enrollment: 1000 participants